WILMINGTON, Mass. (AP) _ Charles River Laboratories International Inc. (CRL) on Tuesday reported a fourth-quarter loss of $29.8 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the Wilmington, Massachusetts-based company said it had a loss of 63 cents. Earnings, adjusted for non-recurring costs and to account for discontinued operations, were $1.40 per share.
The results topped Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $1.26 per share.
The medical research equipment and services provider posted revenue of $478.5 million in the period, also topping Street forecasts. Seven analysts surveyed by Zacks expected $476.7 million.
For the year, the company reported profit of $123.4 million, or $2.54 per share. Revenue was reported as $1.86 billion.
Charles River expects full-year earnings in the range of $5.42 to $5.57 per share.
Charles River shares have dropped nearly 7 percent since the beginning of the year. The stock has climbed 22 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CRL at https://www.zacks.com/ap/CRL